Michel Dahan is SVP, Chief Operating Officer of Akebia Therapeutics Inc.
Person profile
Roles
Akebia Therapeutics
SVP, Chief Operating Officer
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Akebia Therapeutics, Inc.
3 Mar 23
4
Akebia Therapeutics, Inc.
1 Mar 23
4
Akebia Therapeutics, Inc.
2 Mar 22
4
Akebia Therapeutics, Inc.
1 Apr 21
4
Akebia Therapeutics, Inc.
18 Mar 21
4
Akebia Therapeutics, Inc.
2 Mar 21
4
Akebia Therapeutics, Inc.
2 Mar 20
4
Akebia Therapeutics, Inc.
12 Apr 19
4
Akebia Therapeutics, Inc.
5 Mar 19
4
Akebia Therapeutics, Inc.
13 Dec 18
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Mar 23 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 0.8775 | 1,878 | 1.65 k | 269,515 |
1 Mar 23 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 0.8775 | 10,476 | 9.19 k | 271,393 |
1 Mar 23 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 0.8775 | 8,058 | 7.07 k | 281,869 |
27 Feb 23 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 0.8132 | 10,090 | 8.21 k | 289,927 |
1 Mar 22 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 2.1707 | 1,232 | 2.67 k | 297,017 |
1 Mar 22 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 2.1707 | 6,873 | 14.92 k | 295,249 |
1 Mar 22 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 2.1707 | 6,873 | 14.92 k | 302,122 |
28 Feb 22 | AKBA Akebia Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 308,995 |
28 Feb 22 | AKBA Akebia Therapeutics | Common Stock | Sell | Dispose S | No | No | 2.1548 | 6,555 | 14.12 k | 258,995 |
28 Feb 22 | AKBA Akebia Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 2.16 | 200,000 | 432.00 k | 200,000 |